CompareMarketResearchRequest a sample
Home / Healthcare / Polymerase Chain Reaction

Healthcare · Market report

Polymerase Chain Reaction Market Size, Share and Forecast 2026-2036

The global polymerase chain reaction market is worth USD 11.6 bn in 2026 and is forecast to reach USD 21.7 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.

USD 11.6 bnMarket size 2026
USD 21.7 bnForecast 2036
6.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global polymerase chain reaction market is worth USD 11.6 bn in 2026 and is forecast to reach USD 21.7 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.

ScopePolymerase chain reaction instruments, reagents, consumables and software for amplifying DNA and RNA in clinical diagnostics, research, pharma and forensic laboratories.
IndustryHealthcare
Value 2025USD 11.0 bn
Value 2026USD 11.6 bn
Value 2036USD 21.7 bn
CAGR 2026-20366.5%
Volume 20261,871 million tests
Volume 20363,180 million tests
Average price 2026USD 6.17 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Polymerase Chain Reaction market size and forecast, 2026-2036

Exhibit 1The global polymerase chain reaction market is forecast to grow from USD 11.6 bn in 2026 to USD 21.7 bn by 2036, a rise of 88%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.5%
Polymerase Chain Reaction market value, 2025 to 2036Market value by year. 2025: USD 11.0 bn; 2026: USD 11.6 bn; 2027: USD 12.3 bn; 2028: USD 13.1 bn; 2029: USD 14.0 bn; 2030: USD 14.9 bn; 2031: USD 15.8 bn; 2032: USD 16.9 bn; 2033: USD 17.9 bn; 2034: USD 19.1 bn; 2035: USD 20.4 bn; 2036: USD 21.7 bn. Compound annual growth rate 2026 to 2036: 6.5%.202511.6 bn202615.8 bn203121.7 bn20366.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 11.6 bn
2027USD 12.3 bn
2028USD 13.1 bn
2029USD 14.0 bn
2030USD 14.9 bn
2031USD 15.8 bn
2032USD 16.9 bn
2033USD 17.9 bn
2034USD 19.1 bn
2035USD 20.4 bn
2036USD 21.7 bn

Polymerase Chain Reaction market segmentation

By product

Exhibit 2Reagents and consumables is the largest segment by product, with 62.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Polymerase Chain Reaction market share by product, 2026Share of 2026 revenue by product. Reagents and consumables: 62.0%; Instruments: 28.0%; Software and services: 10.0%.Reagents and consumables62.0%Instruments28.0%Software and services10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Reagents and consumables62.0%61.5%USD 7.2 bn6.4%
Instruments28.0%26.5%USD 3.2 bn5.9%
Software and services10.0%12.0%USD 1.2 bn8.4%

By technology

Exhibit 3Real-time PCR adds the most revenue by technology, growing from USD 6.0 bn in 2026 to USD 10.6 bn by 2036Estimated revenue in USD by technology, 2026 and 2036 forecast
Polymerase Chain Reaction market by technology, 2026 and 2036Revenue by technology in 2026 and 2036. Real-time PCR: USD 6.0 bn in 2026, USD 10.6 bn in 2036, change +76%; Digital PCR: USD 1.6 bn in 2026, USD 4.5 bn in 2036, change +179%; Multiplex and specialty: USD 1.6 bn in 2026, USD 3.4 bn in 2036, change +112%; Conventional PCR: USD 2.3 bn in 2026, USD 3.2 bn in 2036, change +38%.20262036 forecastChangeReal-time PCR+76%6.0 bn10.6 bnDigital PCR+179%1.6 bn4.5 bnMultiplex and specialty+112%1.6 bn3.4 bnConventional PCR+38%2.3 bn3.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Real-time PCR52.0%48.7%USD 6.0 bn5.8%
Conventional PCR20.0%14.7%USD 2.3 bn3.3%
Digital PCR14.0%20.8%USD 1.6 bn10.8%
Multiplex and specialty14.0%15.8%USD 1.6 bn7.8%

By end use

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Clinical diagnostics48.0%48.4%USD 5.5 bn6.6%
Academic and research26.0%23.9%USD 3.0 bn5.6%
Pharma and biotech16.0%18.6%USD 1.8 bn8.1%
Forensic and other10.0%9.2%USD 1.2 bn5.6%

By application

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Infectious disease34.0%28.0%USD 3.9 bn4.5%
Oncology22.0%26.0%USD 2.5 bn8.3%
Genetic testing14.0%16.0%USD 1.6 bn7.9%
Research and gene expression20.0%20.0%USD 2.3 bn6.5%
Food and environmental10.0%10.0%USD 1.2 bn6.5%

By sample throughput

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Low under 96 well30.0%26.0%USD 3.5 bn5.0%
Mid range38.0%38.0%USD 4.4 bn6.5%
High throughput automated32.0%36.0%USD 3.7 bn7.8%

Top 25 countries for polymerase chain reaction by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 94.6%.

Exhibit 4United States is the largest country market at USD 3.9 bn in 2026, and the three largest countries hold 55.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Polymerase Chain Reaction market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 3.9 bn, 34.0%; China: USD 1.6 bn, 14.0%; Germany: USD 808 mn, 7.0%; Japan: USD 578 mn, 5.0%; United Kingdom: USD 578 mn, 5.0%; France: USD 462 mn, 4.0%; India: USD 462 mn, 4.0%; Italy: USD 346 mn, 3.0%; South Korea: USD 346 mn, 3.0%; Canada: USD 346 mn, 3.0%.United States3.9 bn 34.0%China1.6 bn 14.0%Germany808 mn 7.0%Japan578 mn 5.0%United Kingdom578 mn 5.0%France462 mn 4.0%India462 mn 4.0%Italy346 mn 3.0%South Korea346 mn 3.0%Canada346 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 3.9 bn34.0%USD 7.0 bn5.9%
2ChinaUSD 1.6 bn14.0%USD 3.6 bn8.4%
3GermanyUSD 808 mn7.0%USD 1.4 bn5.4%
4JapanUSD 578 mn5.0%USD 932 mn4.9%
5United KingdomUSD 578 mn5.0%USD 1.0 bn5.8%
6FranceUSD 462 mn4.0%USD 781 mn5.4%
7IndiaUSD 462 mn4.0%USD 1.2 bn9.9%
8ItalyUSD 346 mn3.0%USD 585 mn5.4%
9South KoreaUSD 346 mn3.0%USD 672 mn6.8%
10CanadaUSD 346 mn3.0%USD 607 mn5.8%
11SpainUSD 323 mn2.8%USD 557 mn5.6%
12NetherlandsUSD 193 mn1.7%USD 332 mn5.6%
13SwitzerlandUSD 142 mn1.2%USD 245 mn5.6%
14AustraliaUSD 114 mn1.0%USD 197 mn5.6%
15BrazilUSD 97 mn0.8%USD 236 mn9.3%
16RussiaUSD 84 mn0.7%USD 145 mn5.6%
17TaiwanUSD 75 mn0.7%USD 130 mn5.7%
18BelgiumUSD 68 mn0.6%USD 117 mn5.6%
19SwedenUSD 62 mn0.5%USD 108 mn5.7%
20SingaporeUSD 58 mn0.5%USD 141 mn9.3%
21MexicoUSD 53 mn0.5%USD 132 mn9.6%
22TurkeyUSD 50 mn0.4%USD 124 mn9.5%
23ThailandUSD 47 mn0.4%USD 115 mn9.3%
24Saudi ArabiaUSD 45 mn0.4%USD 111 mn9.4%
25PolandUSD 43 mn0.4%USD 104 mn9.3%
Rest of worldUSD 624 mn5.4%USD 1.1 bn6.1%
Exhibit 5United States and China account for 50% of the USD 10.1 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Polymerase Chain Reaction market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 11.6 bn. United States: +USD 3.1 bn; China: +USD 2.0 bn; India: +USD 730 mn; Germany: +USD 557 mn; United Kingdom: +USD 442 mn; 20 other countries: +USD 2.8 bn; Rest of world: +USD 506 mn. Market value 2036: USD 21.7 bn.Market value 202611.6 bnUnited States+3.1 bnChina+2.0 bnIndia+730 mnGermany+557 mnUnited Kingdom+442 mn20 other countries+2.8 bnRest of world+506 mnMarket value 203621.7 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Thermo Fisher Scientific
  • Roche
  • Bio-Rad Laboratories
  • QIAGEN
  • Danaher
  • Abbott

Group 2: Regional and specialist players

  • Agilent Technologies
  • Takara Bio
  • Hologic
  • bioMerieux
  • Cepheid
  • Revvity
  • Seegene
  • Eppendorf
  • DiaSorin

Group 3: Emerging and niche players

  • Sansure Biotech
  • Analytik Jena
  • Daan Gene
  • Bioer Technology
  • Bioneer

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the polymerase chain reaction market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.

The market is divided by product, by technology, by end use, by application, by sample throughput. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the polymerase chain reaction market?

The global polymerase chain reaction market is estimated at USD 11.0 bn in 2025 and USD 11.6 bn in 2026.

How fast will the polymerase chain reaction market grow?

It is forecast to reach USD 21.7 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 10.1 bn.

Which country is the largest market for polymerase chain reaction?

United States is the largest market by revenue at USD 3.9 bn in 2026, 34.0% of the global total. The three largest countries together hold 55.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.9% a year from 2026 to 2036.

Which polymerase chain reaction segment is largest?

In the by product split, Reagents and consumables is the largest segment with 62.0% of 2026 revenue.

Who are the leading polymerase chain reaction companies?

Global leaders include Thermo Fisher Scientific, Roche, Bio-Rad Laboratories, QIAGEN.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Point-of-Care Respiratory Diagnostic Panels Precision Medicine →

All Healthcare markets →

Request a sample